Indonesia
# |
Name |
Shareholders' Equity |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 1.39 B
|
Dec. 31, 2023 | USD 0.07 | -5.68% |
|
Indonesia |
|
2 |
USD 155.94 M
|
Dec. 31, 2023 | USD 0.04 | -2.78% |
|
Indonesia |
|
3 |
USD 103.34 M
|
Dec. 31, 2023 | USD 0.02 | -2.87% |
|
Indonesia |
|
4 |
USD 51.73 M
|
Dec. 31, 2023 | USD 0.21 | -0.01% |
|
Indonesia |
|
5 |
USD 23.19 M
|
Dec. 31, 2023 | USD 0.01 | -3.10% |
|
Indonesia |
|
6 |
USD 12.71 M
|
Dec. 31, 2023 | USD 0.01 | -3.26% |
|
Indonesia |
The Biotechnology company in Indonesia with the highest Shareholders' Equity is PT Kalbe Farma Tbk. (Jakarta Stock Exchange: KLBF.JK) at USD 1.39 B.
The Biotechnology company in Indonesia with the lowest Shareholders' Equity is PT Diagnos Laboratorium Utama Tbk (Jakarta Stock Exchange: DGNS.JK) at USD 12.71 M.
The top 10 Biotechnology companies in Indonesia by Shareholders' Equity are PT Kalbe Farma Tbk., PT Soho Global Health Tbk, PT Bundamedik Tbk, PT Merck Tbk, PT Pyridam Farma Tbk and PT Diagnos Laboratorium Utama Tbk.
The bottom 10 Biotechnology companies in Indonesia by Shareholders' Equity are PT Diagnos Laboratorium Utama Tbk, PT Pyridam Farma Tbk, PT Merck Tbk, PT Bundamedik Tbk, PT Soho Global Health Tbk and PT Kalbe Farma Tbk..